Literature DB >> 30546661

Chronic total occlusions of the right coronary and left anterior descending coronary arteries in a young adult patient with antiphospholipid syndrome.

Yasuyuki Kawai1, Michihiko Kitayama2, Atsushi Motoyama1, Minoru Wakasa1, Ryuhei Saito1, Hirofumi Aoki1, Kousuke Fujibayashi1, Makoto Watanabe1, Takaaki Takamura1, Hironobu Akao1, Taketsugu Tsuchiya2, Kouji Kajinami1.   

Abstract

A 36-year-old male appeared to have an old myocardial infarction on electrocardiogram, and coronary angiography (CAG) was performed. The CAG showed total occlusions of the right coronary artery and left anterior descending artery. He was successfully treated with drug-eluting stent implantation for both occluded coronary arteries. Such serious coronary lesions are uncommon for his young age. The patient was diagnosed as having antiphospholipid syndrome (APS) based on elevation of anticardiolipin antibody and anti-β2 glycoprotein I antibody. Two years after stent implantation, the patient was well without ischemia or thrombosis. APS should be considered a potential cause of serious coronary disease in young adults. <Learning objective: Antiphospholipid syndrome (APS) should be considered a potential cause of serious coronary disease in young adults. Although there is a high risk of acute stent thrombosis and restenosis after multiple stents implantation, percutaneous coronary intervention with drug-eluting stent implantation could be an appropriate therapy for chronic total occlusion in APS patients.>.

Entities:  

Keywords:  Antiphospholipid syndrome; Chronic total occlusion; Myocardial infarction; Young adult

Year:  2016        PMID: 30546661      PMCID: PMC6282882          DOI: 10.1016/j.jccase.2016.03.014

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Primary percutaneous coronary intervention for acute myocardial infarction due to possible sequelae of Kawasaki disease in young adults: a case series.

Authors:  Makoto Ariyoshi; Jun Shiraishi; Masayoshi Kimura; Akihiro Matsui; Mitsuo Takeda; Masayasu Arihara; Masayuki Hyogo; Takatomo Shima; Takashi Okada; Yoshio Kohno; Takahisa Sawada; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

2.  Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention.

Authors:  Leor Perl; Adi Netzer; Eldad Rechavia; Tamir Bental; Abid Assali; Pablo Codner; Aviv Mager; Alexander Battler; Ran Kornowski; Eli I Lev
Journal:  Cardiology       Date:  2012-06-20       Impact factor: 1.869

3.  Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome.

Authors:  Adalet Gürlek; Cagdaş Ozdöl; Gülgün Pamir; Irem Dinçer; Hüseyin Tutkak; Derviş Oral
Journal:  Int Heart J       Date:  2005-07       Impact factor: 1.862

4.  Antiphospholipid syndrome and acute myocardial infarction: treatment with thrombectomy and abciximab.

Authors:  Vicens Martí; Filipe Seixo; Miguel Santaló; Antonio Serra
Journal:  Rev Port Cardiol       Date:  2014-08-13       Impact factor: 1.374

5.  Recurrent acute coronary events in a young adult.

Authors:  Suman B Thapamagar; Thein T Aung; Daniel Mascarenhas
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

6.  Intra-vascular ultrasound findings of diffuse coronary atherosclerotic change in systemic lupus erythematosus with secondary antiphospholipid syndrome.

Authors:  Yasumasa Ikeda; Shusuke Yagi; Hiroshi Yamaguchi; Mitsunori Fujimura; Shunji Hashizume; Ken-ichi Aihara; Masashi Akaike; Hiroyuki Azuma; Toshio Matsumoto
Journal:  Circ J       Date:  2006-08       Impact factor: 2.993

7.  Acute thrombotic occlusion of right coronary and left circumflex coronary arteries in a patient with antiphospholipid syndrome: successful stent implantation.

Authors:  Serdar Biceroglu; Muge Ildizli Demirbas; Mustafa Karaca; Murat Yalcin; Hasan Yilmaz
Journal:  Case Rep Med       Date:  2010-10-26

Review 8.  Antiphospholipid syndrome.

Authors:  Diane George; Doruk Erkan
Journal:  Prog Cardiovasc Dis       Date:  2009 Sep-Oct       Impact factor: 8.194

Review 9.  Cardiac manifestations in antiphospholipid syndrome.

Authors:  Pál Soltész; Zoltán Szekanecz; Emese Kiss; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2007-01-31       Impact factor: 9.754

Review 10.  Antiphospholipid syndrome: an overview.

Authors:  John G Hanly
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.